Trials / Unknown
UnknownNCT03795155
Prospective Genomics Initiative on Multiple Synchronous Lung Cancer (PGI-MSLC)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective study is to characterize the genomic landscape and genetic heterogeneity of multiple synchronous lung cancer (MSLC) in correlation with comprehensive clinical, histopathological and medical imaging information, in order to improve disease diagnosis and tailored treatment for MSLC patients.
Detailed description
* To initiate a prospective registry of MSLC patients with high-quality clinical samples and detailed medical data. * To define the clonal relationship, genomic landscape and potential driver alterations of MSLC using whole-genome sequencing. * To determine the intrapatient and intratumor genetic heterogeneity of MSLC. * To correlate molecular features with clinical parameters and patient outcome. * To serve as a continuous infrastructure for a large variety of research purposes including: A. Diagnostic research B. Prognostic research C. Biological research D. Interventional trial design testing new therapies in MSLC.
Conditions
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2022-11-30
- Completion
- 2023-11-30
- First posted
- 2019-01-07
- Last updated
- 2020-06-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03795155. Inclusion in this directory is not an endorsement.